Search
Displaying 291–300 of 543 for “Retinitis pigmentosa”
-
AGTC Planning Phase 2/3 Clinical Trial for XLRP Gene Therapy
Research NewsThe company is also expanding its Phase ½ trial for the emerging treatment
-
Research News
A Phase 3 trial for the treatment is planned
-
Bionic Sight Doses First Patient in Clinical Trial for Optogenetic Therapy
Research NewsTreatment combines gene therapy and a device that generates and delivers retinal code
-
Abfero Targeting Excess Iron to Treat AMD, Other Retinal Diseases
Partner NewsAn intriguing link between excess body iron and retinal degeneration is being explored by Abfero Pharmaceuticals, a young biotech based in Boston and Oxford, UK.
-
Lulie Gund: Beloved Philanthropist, Role Model and Confidant
Beacon StoriesLlura Gund, often referred to as Lulie, was known for her infectious kind smile and love of life.
-
Nacuity’s Emerging Anti-Oxidative Therapy Moves into Clinical Trial
Research NewsThe oral treatment shows promise for slowing vision loss in people with RP and Usher syndrome, regardless of genetic profile
-
jCyte Enters into Licensing Agreement with Santen Pharmaceutical for Cell Therapy
Research NewsEmerging treatment designed to preserve vision for people with RP and related conditions
-
#GivingTuesdayNow Featured Researcher Dr. Shannon Boye
Research NewsA Lifelong Science Nerd is Winning the Fight Against Blindness
-
Coping with COVID-19: Welcome to the “New Normal”
Beacon StoriesWe checked in with a few of the Foundation’s volunteers to get their perspective on these unprecedented times.
-
Interim Results Released for USH2A RNA Therapy Clinical Trial
Research NewsSuggestions of efficacy observed in 25 percent of participants receiving the treatment
